Jonathan Slonin, Chief Clinical Officer at Pacira BioSciences, Inc. (PCRX), sold 1,848 shares at $57.19 ($106K) on 2022-07-05, disclosed to the SEC on 2022-07-07.
Open-market sale of $106k PCRX by Chief Clinical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.19 | 924 | $53K | 50.0% |
| 2 | $57.19 | 924 | $53K | 50.0% |
| Total | $57.19 avg | 1,848 | $106K | 100% |
| Filing → |
| PCRX | SELL | 2025-11-19 | $191K | — | Filing → |
| PCRX | SELL | 2025-01-06 | $16K | — | Filing → |
| PCRX | SELL | 2024-08-02 | $19K | — | Filing → |